Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business – GenomeWeb
NEW YORK Quidel said on Monday that it and Beckman Coulter have reached a settlement of a legal dispute over the Triage B-type naturietic peptide, or BNP, assay business.
As part of the settlement, Quidel will supply reagents for the assay while transitioning…
